Related Experiment Video
Updated: Apr 23, 2026
07:59
Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis
Published on: May 18, 2016
7.2K
Trypanosomatids see the light: recent advances in bioimaging research
Estefanía Calvo-Álvarez1, Raquel Álvarez-Velilla1, Christopher Fernández-Prada2
1Departamento de Ciencias Biomédicas, Universidad de León, Campus de Vegazana s/n, 24071 León, Spain.
Drug Discovery Today
|September 27, 2014
Summary
Genetically engineered pathogens expressing light-emitting proteins advance tropical disease research. These tools aid drug screening, reduce animal use in studies, and help understand parasite genetic exchange.
Area of Science:
- Biotechnology
- Tropical Medicine
- Parasitology
Background:
- Trypanosomatid-borne diseases pose significant global health challenges.
- Understanding parasite biology, virulence, and drug resistance is crucial for effective treatment.
- Current research methods can be resource-intensive and ethically concerning.
Purpose of the Study:
- To highlight the advancements in understanding trypanosomatid-borne tropical diseases using genetically engineered pathogens.
- To showcase the utility of these modified pathogens in drug discovery and preclinical research.
- To emphasize their role in elucidating genetic exchange mechanisms in trypanosomatids.
Main Methods:
- Development of genetically engineered trypanosomatid pathogens expressing fluorescent or luminescent proteins.
- Application of these modified parasites in high-throughput phenotypic drug screening.
- Utilizing transgenic parasites in experimental infections to monitor parasite load non-invasively.
- Employing fluorescent parasites to study genetic exchange events.
Main Results:
- Genetically engineered pathogens provide a powerful tool for studying tropical diseases.
- Phenotypic screening using modified microorganisms accelerates compound discovery.
- Transgenic parasites significantly reduce the number of animals needed for preclinical studies.
- Fluorescent parasites facilitate the investigation of genetic exchange and trait transfer.
Conclusions:
- Genetically engineered pathogens represent a significant advancement in trypanosomatid research.
- These tools enhance drug screening efficiency, reduce animal experimentation, and improve understanding of parasite genetics.
- This approach is vital for developing new strategies against tropical diseases and emerging parasite strains.
